MedDataX Logo

Carboxytherapy for Periorbital Dark Circles

NCT ID: NCT04745078

Last Updated: 2021-11-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-01

Study Completion Date

2021-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

the study evaluates carboxytherapy for the treatment of periorbital dark circles

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

two different concentrations of carboxytherapy administered to patients are compared regarding efficacy

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Periorbital Disorder

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

carboxytherapy dark circles

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Carboxy30

carboxy30

Group Type ACTIVE_COMPARATOR

Caboxy30

Intervention Type OTHER

carboxy30 to periorbital dark halos

Carboxy60

carboxy60

Group Type ACTIVE_COMPARATOR

Caboxy60

Intervention Type OTHER

carboxy60 to periorbital dark halos

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Caboxy30

carboxy30 to periorbital dark halos

Intervention Type OTHER

Caboxy60

carboxy60 to periorbital dark halos

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Carboxy30

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy individuals with dark circles

Exclusion Criteria

* infections, scarring, pregnancy, allergy, on treatment for the condition.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alexandria University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Heba Mahmoud

principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ossama H Roushdy, MD

Role: STUDY_CHAIR

University of Alexandria

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Medicine,Alexandria University

Alexandria, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0104074

Identifier Type: -

Identifier Source: org_study_id